Review



erbb signaling pathway epithelial cell signaling  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Cell Signaling Technology Inc erbb signaling pathway epithelial cell signaling
    Pairs of pathway interactions from 2 different drugs with the greatest DCSC score.
    Erbb Signaling Pathway Epithelial Cell Signaling, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/erbb signaling pathway epithelial cell signaling/product/Cell Signaling Technology Inc
    Average 92 stars, based on 22 article reviews
    erbb signaling pathway epithelial cell signaling - by Bioz Stars, 2026-05
    92/100 stars

    Images

    1) Product Images from "Pathway Interactions Based on Drug-Induced Datasets"

    Article Title: Pathway Interactions Based on Drug-Induced Datasets

    Journal: Cancer Informatics

    doi: 10.1177/1176935119851518

    Pairs of pathway interactions from 2 different drugs with the greatest DCSC score.
    Figure Legend Snippet: Pairs of pathway interactions from 2 different drugs with the greatest DCSC score.

    Techniques Used: Infection

    Interactions of drugs, pathways, and diseases in our and previous studies. (A) Red arrows present the drug to cancer pathway via MTOR as in Chiu et al. (B) Blue arrows present sirolimus to pancreatic cancer pathways via MTOR and ERBB as in Hynes and MacDonald. (C) The ERBB signaling pathway is the primary choice for the breast cancer treatment. – (D) Description of our findings (black arrows) compared with previous studies.
    Figure Legend Snippet: Interactions of drugs, pathways, and diseases in our and previous studies. (A) Red arrows present the drug to cancer pathway via MTOR as in Chiu et al. (B) Blue arrows present sirolimus to pancreatic cancer pathways via MTOR and ERBB as in Hynes and MacDonald. (C) The ERBB signaling pathway is the primary choice for the breast cancer treatment. – (D) Description of our findings (black arrows) compared with previous studies.

    Techniques Used:



    Similar Products

    92
    Cell Signaling Technology Inc erbb signaling pathway epithelial cell signaling
    Pairs of pathway interactions from 2 different drugs with the greatest DCSC score.
    Erbb Signaling Pathway Epithelial Cell Signaling, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/erbb signaling pathway epithelial cell signaling/product/Cell Signaling Technology Inc
    Average 92 stars, based on 1 article reviews
    erbb signaling pathway epithelial cell signaling - by Bioz Stars, 2026-05
    92/100 stars
      Buy from Supplier

    Image Search Results


    Pairs of pathway interactions from 2 different drugs with the greatest DCSC score.

    Journal: Cancer Informatics

    Article Title: Pathway Interactions Based on Drug-Induced Datasets

    doi: 10.1177/1176935119851518

    Figure Lengend Snippet: Pairs of pathway interactions from 2 different drugs with the greatest DCSC score.

    Article Snippet: 17-AAG_wort , 3/1 , ERBB SIGNALING PATHWAY/EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION , 3.94 , 6.

    Techniques: Infection

    Interactions of drugs, pathways, and diseases in our and previous studies. (A) Red arrows present the drug to cancer pathway via MTOR as in Chiu et al. (B) Blue arrows present sirolimus to pancreatic cancer pathways via MTOR and ERBB as in Hynes and MacDonald. (C) The ERBB signaling pathway is the primary choice for the breast cancer treatment. – (D) Description of our findings (black arrows) compared with previous studies.

    Journal: Cancer Informatics

    Article Title: Pathway Interactions Based on Drug-Induced Datasets

    doi: 10.1177/1176935119851518

    Figure Lengend Snippet: Interactions of drugs, pathways, and diseases in our and previous studies. (A) Red arrows present the drug to cancer pathway via MTOR as in Chiu et al. (B) Blue arrows present sirolimus to pancreatic cancer pathways via MTOR and ERBB as in Hynes and MacDonald. (C) The ERBB signaling pathway is the primary choice for the breast cancer treatment. – (D) Description of our findings (black arrows) compared with previous studies.

    Article Snippet: 17-AAG_wort , 3/1 , ERBB SIGNALING PATHWAY/EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION , 3.94 , 6.

    Techniques: